Quick context
MOTS-c
研究方向包括细胞能量代谢、胰岛素敏感性、肥胖和骨生物学。
No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.
Back to all 64 profiles
Community/research information only未获 FDA/EMA 批准
Community protocol · MOTS-c
MOTS-c: community information and evidence, clearly separated.
A complete substance profile covering documented community themes, scientific context and explicit safety boundaries. Missing or non-standardised data are not replaced with estimates.
Also known as: MOTS-c (Human) · Mitochondrial open reading frame peptide
Sources checked: 27 August 2026
重要安全与责任声明
本页记录并评估网络社区信息，不构成医疗或治疗建议、个体咨询，也不是使用邀请。
No medical, therapeutic or individual recommendation. Information is provided without warranty and used at your own risk. No liability for calculation errors, use, contamination, interactions or consequences.
Amounts, timing and cycles
Community/research information only
No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.
Amount status
Different amounts circulate online; no regulator-confirmed safe or effective dose exists.
Profile evidence level: preclinical.
Timing
Community claims about time of day, fasting windows or training intervals are not validated clinical standards.
No individual recommendation.
Cycle/duration
Cycles and breaks are community constructs and do not prevent adverse effects or unknown long-term consequences.
No individual recommendation.
External community reference available
The external page is used only to document community claims. Advertising and affiliate material were excluded; its content is neither approval nor proof of quality.
Open community source复配与 U-100 换算
复配计算器
For clearly identified single lyophilised substances, the calculator only shows the arithmetic between vial amount, liquid volume and target amount. It does not check identity, purity, sterility, solubility, stability or solvent suitability. The entered target is not a recommendation.
复配计算器
Calculates concentration, volume and theoretical U-100 units. The preloaded 200 µg is only the reference page's arithmetic example.
Concentration
3,333.33 µg/ml
Calculated volume
0.06 ml
U-100 units
6 U
Calculated portions per vial
50
Calculation aid, not dosage or use advice. Incorrect inputs, a different syringe scale, measurement error, dead space or unknown vial content produce incorrect results.
Mechanism and research questions
Mitochondrial-derived 16-amino-acid peptide
MOTS-c is classified as “Mitochondrial-derived 16-amino-acid peptide”. 研究方向包括细胞能量代谢、胰岛素敏感性、肥胖和骨生物学。 This describes the investigated pathway but does not validate a community use, amount, route or combination.
线粒体肽
研究人员研究某肽如何与细胞的动力工厂——线粒体相互作用,并影响其能量产生。测量指标包括细胞模型中的耗氧量和能量周转。
细胞能量代谢
研究人员研究细胞如何通过线粒体产生和使用能量,类似于测量发动机燃烧燃料的效率。常见测量指标包括细胞模型中的耗氧量和能量输出。
血糖与食欲结果
研究人员研究某物质如何在一天中改变血糖水平和饥饿感,类似于观察不同餐食后一个人的饱腹感。常见测量指标包括血糖读数以及关于饥饿感和进食量的问卷。
What communities discuss
These themes describe discussion and vendor claims. They do not prove benefit, safety, product identity or suitable use.
生物黑客与长寿论坛
用户比较自行组合的肽方案,以期影响衰老过程或能量水平,常常依据血液检测或主观幸福感量表。个人自我实验和营销承诺无法取代对照的长期人体研究。
精力与疲劳轶事
人们报告在使用线粒体肽或维生素注射后主观感受到的精力提升,通常基于个人每日精力评分。这类印象极易受安慰剂效应影响。
抗衰老论坛
这里比较生长轴、线粒体和皮肤相关肽的组合方案,目的是影响可见或可感知的衰老迹象,通常经过多年个人记录。关于延缓衰老的轶事和商家广告并非科学证据。
Adverse effects and risk boundaries
- 能量与线粒体通路遍及多个器官。可能出现疲劳、头痛、循环、代谢或器官特异性影响；长期数据可能有限。
- Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
- A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.
Exclusion groups and professional assessment
- 妊娠/哺乳及严重心脏、肝脏、肾脏或代谢疾病需要针对适应证的专科评估。
- Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
- Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.
Monitoring and laboratory markers
- 根据研究问题，可测量生命体征、功能能力、乳酸/代谢指标及器官功能；在明确研究之外通常无统一标准。
- Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.
Evidence boundary
临床前
相关研究大多处于临床前阶段;关于人体的结论仍属初步。
Published evidence
现有数据主要来自动物或细胞模型;缺乏可靠的人体有效性和安全性数据。
MOTS-c由线粒体DNA编码,而艾拉莫肽是一种与线粒体结合的合成四肽。
Storage and stability
- The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
- Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
- Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.
Troubleshooting and error sources
- U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
- Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
- Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
- Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.
Regulatory status and WADA
未获 FDA/EMA 批准
没有 FDA 或 EMA 批准的药品；有效性与安全性尚未确立。
WADA 2026
The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.
WADA — 2026 Prohibited ListComparisons and related profiles
Combinations / stacks
- Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
- Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
- Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.
Frequently asked questions
Is an amount shown here a recommendation?
No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.
Does the U-100 calculator prove correct use?
No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.
Can this profile be combined with other substances?
Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.
Which source controls when information conflicts?
For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.
Are community claims clinical evidence?
No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.
Sources and evidence layers
Primary sources and official registries take priority. The community reference is labelled separately.
- Primary/technical sourceFDA: 2026 peptide advisory review
- Community referenceMOTS-c — Peptide Dosing Protocols